This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

Completed · Phase 2 · Has a placebo group

Conditions studied: Carcinoma, Non-Small-Cell Lung

In brief

The purpose of this study is to compare the efficacy of ZD6474 and ZD1839 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.

Key facts

Study ID

NCT00059722

Run by

Genzyme, a Sanofi Company

People needed

160

Starts

2003-05-01

Expected to finish

2007-06-01

Last updated by the study team

2016-08-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Failure of either first-line and/or second-line chemotherapy either of which was platinum-based (the prior regimen must have failed the subject because of toxicity or progression of tumor
• Prior histologic or cytologic confirmation of locally advanced or metastatic (IIIB/IV) NSCLC

You may not qualify if…

• Subjects who have received second-line or subsequent chemotherapy
• Any evidence of clinically active interstitial lung disease (patients with chronic, stable, radiographic changes who are asymptomatic, need not be excluded)

Where it is running

• Research Site — Pine Bluff, Arkansas, United States
• Research Site — Los Angeles, California, United States
• Research Site — Palm Springs, California, United States
• Research Site — San Diego, California, United States
• Research Site — Boca Raton, Florida, United States
• Research Site — Jacksonville, Florida, United States
• Research Site — Orange Park, Florida, United States
• Research Site — Coeur d'Alene, Idaho, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Indianapolis, Indiana, United States
• Research Site — Shreveport, Louisiana, United States
• Research Site — Saint Loius, Missouri, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Brooklyn, New York, United States
• Research Site — New York, New York, United States
• Research Site — Greenville, North Carolina, United States
• Research Site — Bismarck, North Dakota, United States
• Research Site — Madison, Wisconsin, United States
• Research Site — Buenos Aires, Argentina
• Research Site — Mendoza, Argentina
• Research Site — Brussels, Belgium
• Research Site — Brussels (Jette), Belgium
• Research Site — Brussels (Woluwé-St-Lambert), Belgium
• Research Site — Edegem, Belgium
• Research Site — Liège, Belgium

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.